Early Win for Preemptive Stents on Vulnerable Coronary Plaque
Clinical benefit observed years after preventive PCI on non-flow-limiting plaque in PREVENT trial
Stay updated with breaking news from Marc Bonaca. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Clinical benefit observed years after preventive PCI on non-flow-limiting plaque in PREVENT trial
While the field awaits targeted therapies, estimates of absolute 10-year risks can be used to counsel patients, researchers say.
Cleerly and partners embark on the groundbreaking TRANSFORM trial, harnessing AI's power to personalize heart disease care and....
A group of 13 leading experts provides their perspectives on the top news in cardiovascular medicine from 2023, with responses ranging from novel approvals to new semaglutide data to gene therapy and more.
Bonaca also notes that pharmacists can play a key role in educating patients and clinicians about the appropriate use and dosing of antithrombotic drugs for vascular protection.